The WHO-HAEM4 provisional entity “Burkitt-like lymphoma with 11q aberration” was named as such because of its clinical, morphological (“starry sky pattern”) and immunophenotypic (CD10+/BCL6+/BCL2−/Ki67 high) resemblance to Burkitt lymphoma but lack of MYC rearrangement [119–121]. This evidence concerns the gene MME and Burkitt lymphoma.